Reuters logo
5 months ago
BRIEF-European Medicines Agency's CHMP recommends approval of Merck's keytruda
March 24, 2017 / 1:15 PM / 5 months ago

BRIEF-European Medicines Agency's CHMP recommends approval of Merck's keytruda

March 24 (Reuters) - Merck & Co Inc:

* European Medicines Agency's CHMP recommends approval of Merck's keytruda (pembrolizumab) for the treatment of patients with relapsed or refractory classical hodgkin lymphoma

* Merck & Co Inc- decision on approval is expected in Q2 of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below